
"Nothing Wrong Done By...": Lawyer On Air India vs UK Law Firm Over Compensation
Legal experts from the US and the UK are leading the efforts to file lawsuits against Boeing - the manufacturer of the aircraft that crashed on June 12 in Ahmedabad. The AI171 crash was one of the worst in recent history, in which 241 people onboard the plane were killed and only one survived.
Air India had announced that it would provide an interim compensation of Rs 25 lakh or approximately GBP 21,500 to the families of each of the victims and survivors of the airline's crash to help address immediate financial needs. This, it said, is in addition to the compensation of Rs 1 crore announced by its parent company, Tata Sons.
However, families of the victims have accused the Tata Group-owned airline of "forcing" them to make financial disclosures under the "threat of receiving no advance compensation", even as the carrier "categorically rejected" the allegations and said efforts are being made to process the payments.
'Nothing Wrong Has Been Done'
Speaking to NDTV, James Healy-Pratt, Aviation Partner, Keystone Law, London, who is leading the legal effort, countered the claim and said, "In my view, and having spoken with a lot of British families, I can see nothing that has been done wrong by Air India or their insurers."
James Healy-Pratt and Owen Hanna from UK-based Keystone Law, along with aviation experts from the US-based Wisner Law Firm, are leading the legal effort. A similar case will be filed against Air India in the High Court in London.
According to Stewarts, the UK's largest litigation-only law firm, families of the victims alleged that they are being forced to fill out a questionnaire "in intense heat with no guidance on the terms and questions within it".
Mr Healy-Pratt, however, said He was in contact with the London lawyers for Air India and their insurers yesterday, and I made the same point. "Look, let's concentrate on helping the families process the payments...It's a non-issue. There's no point driving between families and Air India. I mean, why would one do that?"
'Focus Primarily On Air India, Boeing'
"The focus is primarily on Air India and Boeing...The aircraft manufacturer (Boeing) has had a checkered past over the last decade," he said.
Mr Healy-Pratt pointed out the whistle-blowing issues that have surrounded Boeing for several years. "The Boeing 737-Max's, the deferred prosecution in the United States and billions of dollars of fines...But more importantly, it's the consensus among the deployment of Ram Air Turbine (RAT)...Now we don't know at what point, we are assuming it was probably just past the rotation."
Ram Air Turbine or RAT - a small propeller-like device is deployed automatically when there is a dual-engine failure or total electronic or hydraulic failure.
He said that there are 10 reasons for the deployment of RAT if we look at the Flight Crew Operating Manual (FCOM), adding that there are three primary reasons: Double engine failure, an electric failure or a hydraulic failure. He said, "That's bad news if you've just taken off...Then the question is what caused the RAT to deploy."
The legal expert said the preliminary report will provide some indication about what happened...he added that there is consensus that there was a loss of thrust.
The planned lawsuits would be separate from any other efforts Tata Sons, which owns Air India, might be making to support or compensate the victims' families, including financial help.
The Montreal Convention 1999 establishes airline liability in the case of death or injury to passengers, as well as in cases of delay, damage or loss of baggage and cargo. Air India would need to fully meet the compensation norms of the Montreal Convention in financially supporting the families of those who have been killed in the crash.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Indian Express
5 minutes ago
- New Indian Express
NTR district sets Rs 18.23 lakh crore GDP target under Swarnandhra Vision
VIJAYAWADA: NTR District In-charge Minister Y Satya Kumar Yadav announced that draft plans for the development of Vijayawada and other constituencies were prepared based on available resources, with a target of Rs 18.23 lakh crore Gross Domestic Product (GDP). At a review meeting held in Vijayawada on Saturday, the Minister, along with MP Kesineni Sivanath, MLAs Gadde Rammohan, Bonda Umamaheswara Rao, Sriram Rajgopal, Kolikapudi Srinivasa Rao, and Collector G Lakshmisha, discussed progress under the Swarnandhra P4 ('Public, Private, People Partnership) Foundation. They reviewed key sectors including agriculture, industry, services, tourism, food processing, zero-budget natural farming, Farmer Producer Organisations (FPOs), and mechanisation. During the meeting the NTR District In-charge Minister stated, 'P4 is a key chapter in good governance,' and added that implementation will align with Swarnandhra goals through regular reviews. Saty Kumar Yadav said the district's per capita income in 2023–24 stood at Rs 3,21,651, with targets of Rs 6,38,946 by 2028–29 and Rs 1,10,0000 by 2047–48. Swachh Andhra Corporation Chairman K Pattabhiram, Krishna District Cooperative Central (KDCC) Chairman Nettem Raghuram, Joint Collector S Ilakkiya, and Vijayawada Municipal Corporation (VMC) Commissioner Dhanachandra HM also took part in the review meeting.


Indian Express
7 minutes ago
- Indian Express
ED attaches actor Ranya Rao's assets in gold smuggling case: What to know
The Enforcement Directorate (ED) attached assets worth over Rs 34 crore linked to Kannada actor Ranya Rao in a gold smuggling-related money laundering case. On Friday (July 4), the central agency said that false customs declarations were filed in Dubai — where Rao had a travel history — declaring the destination of gold shipments as Switzerland or the US, but in fact, it was for India. 'The attachments have been made in terms of Section 5(1) of the Prevention of Money Laundering Act as property equivalent in value to the untraced proceeds of crime identified during the course of investigation,' the ED said. On March 3, the Directorate of Revenue Intelligence (DRI) arrested Rao at the Bengaluru airport on her arrival from Dubai and recovered 14.2 kg of gold bars valued at more than Rs 12.56 crore from her possession. On March 9, the DRI arrested Telugu actor Tarun Konduru, Rao's accomplice. The ED said, 'Ranya Rao, in active collusion with Tarun Konduru Raju and others, orchestrated a well-structured operation for smuggling gold into India. Gold was procured from suppliers based in Dubai, Uganda, and other jurisdictions, and payments were made through hawala channels in cash, thereby circumventing legal financial systems.' The probe revealed that the smuggled gold was then sold in India to jewellers and other local entities, and the proceeds were laundered through hawala remittances abroad to finance repeat smuggling consignments. Here is what to know. In early March, DRI officials called it 'one of the biggest seizures of gold at Bengaluru airport in recent times.' The DRI was investigating whether the incident was an isolated incident or a part of a series of gold-smuggling trips, noting that Rao, 33, travelled to Dubai 27 times over the previous six months. The case also raised questions on possible police involvement, as local officers would escort Rao home from the airport after she returned from her frequent trips to Dubai. Rao is also the stepdaughter of the senior Karnataka IPS officer K Ramachandra Rao. She is alleged to have used airport protocol services available to her father to escape customs checks and detection at the Bengaluru airport on arrival from Dubai. Earlier this month, the Income Tax (I-T) department said it would investigate Rao's wealth. Until its repeal in 1990, the Gold (Control) Act, 1968, curbed gold imports and heavily restricted the acquisition, possession, and disposal of gold in India. However, with economic liberalisation in the 1990s, the government modified its approach, imposing an import duty on gold at the rate of Rs 250 for every 10 grams, leading to a boom in gold imports in the following years. Gold imports are largely governed by the Customs Act, 1962, and by the Central Board of Indirect Taxes and Customs (CBIC). The customs duty for gold may differ depending on the amount of gold carried by a passenger and the duration spent abroad before travelling back to India, as per the Baggage Rules, 2016 (issued under the Customs Act). Under these rules, a man residing abroad for over a year may carry up to 20 grams of jewellery duty-free (with a value cap of Rs 50,000), and a woman may similarly carry up to 40 grams (with a cap of Rs 1 lakh). The CBIC also has specific guidelines for Indian passengers returning from Dubai after residing there for over six months, allowing them to carry up to 1 kg of gold as long as the applicable customs duty is paid. The customs duty for gold is: 3% customs duty: for men carrying 20-50 grams of gold and women carrying 40-100 grams; 6% customs duty: for men carrying 50-100 grams and women carrying 100-200 grams; 10% customs duty: For men carrying over 100 grams and women carrying over 200 grams. In 2003, the Supreme Court held that any article imported without complying with the relevant conditions or restrictions must be considered a 'prohibited good'. Such goods are liable to be confiscated under Section 111 and punished under Section 112 of the Customs Act. The punishment may include a fine of up to the value of the goods. Section 135 provides a punishment of up to 7 years imprisonment if the market price of the smuggled goods exceeds Rs. 1 lakh. Smuggling is also punishable under Section 111 (Organised Crime) of the Bharatiya Nyaya Sanhita, 2023, which punishes 'trafficking in…illicit goods' with imprisonment of at least five years, extendable to life imprisonment. The Unlawful Activities (Prevention) Act (UAPA) also carries the same punishment for smuggling as a 'terrorist act' under Section 15 if it causes 'damage to the monetary stability of India'. This is an updated version of an explainer published earlier this year.


Mint
10 minutes ago
- Mint
Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report
New Delhi [India], July 6 (ANI): Pharmaceutical firms are expected to post 11 per cent year-on-year growth in both sales and EBITDA for the first quarter of Financial Year 2026 (Q1FY26), driven by sustained momentum across most markets, according to a report by Kotak Institutional Equities. However, the report added that the muted domestic demand in April and March may slightly offset gains. The hospitals segment is projected to see robust 17 per cent year-on-year growth in both sales and EBITDA, supported by increased footfalls, new bed additions, and a modest rise in ARPOB. In diagnostics, volume growth, better mix, and M&A activity are expected to contribute to a 14 per cent YoY sales increase across the coverage. "For pharma companies, we expect continued traction across most markets to drive 11%/11% yoy growth in overall sales/EBITDA in 1QFY26," the report added. India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion. The domestic pharma industry is considered to be the world's third largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level. According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry i.e. Pharmaceuticals, medicinal and botanical products is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is ₹ 1,75,583 crores. As per government data 9,25,811 number of persons are engaged in Pharmaceuticals, medicinal and botanical products industry during FY 2022-23. Research & Development (R&D) and innovation in Pharma Sector is done by number of institutions and organizations under various scientific Ministries/Departments. The Department of Pharmaceuticals has set up seven National Institutes of Pharmaceutical Education & Research (NIPERs) as institutes of national importance, which besides imparting postgraduate and doctorate education, conduct high end research in various pharma specializations. Further, Department has framed a "National Policy on Research & Development and Innovation in Pharma-MedTech Sector in India" to encourage R&D in pharmaceuticals and medical devices.